Stock Information
Celldex Therapeutics Inc (CLDX)
Ticker Symbol: CLDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,114.57 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -4.36
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -52.35%
Latest News
-
Celldex Therapeutics: Trying To Put Its Troubled History Behind It
Wed, Oct 7, 2026 6:05 AM
Key Financials
Financial data not available